Successful treatment of massive stage IIIB cervical cancer with a spindle cell component: A case report.

Medicine (Baltimore)Sep 11, 2026

Hua Jin, Zhengri Piao, Weibo Wen

✦ AI-curated · Sources linked

Case in brief

A 33-year-old woman presented with a massive cervical mass measuring 14 × 13 × 13 cm, accompanied by intermittent vaginal bleeding and progressive fatigue. Biopsy confirmed stage IIIB cervical squamous cell carcinoma with a spindle cell component. The patient underwent neoadjuvant chemotherapy, followed by concurrent chemoradiotherapy and bevacizumab, resulting in complete remission at 6 months with no signs of recurrence or metastasis.

What made this case unusual

The case highlights the successful management of a giant cervical tumor, which is rarely encountered and lacks established treatment protocols.

Diagnostic / clinical pearl

This case underscores the potential of individualized sequential multimodal therapy in achieving complete remission in patients with bulky stage IIIB cervical cancer.

Why it matters

The findings may inform treatment strategies for similarly large cervical tumors, emphasizing the importance of a tailored approach in oncology.

Source

Published in Medicine (Baltimore). This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.